Orexin/hypocretin and major psychiatric disorders-Reference-Cited by-同舟云学术

Orexin/hypocretin and major psychiatric disorders

Published:2022 Issue: Volume: Page:185-212
ISSN:0065-2423
Container-title:Advances in Clinical Chemistry
language:
Short-container-title:

Author:

Lin Chin-Chuen,Huang Tiao-Lai

Publisher

Elsevier

Reference103 articles.

1. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity;de Lecea;Proc. Natl. Acad. Sci. U. S. A.,1998

2. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior;Sakurai;Cell,1998

3. Orexin system: the key for a healthy life;Chieffi;Front. Physiol.,2017

4. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders;Xu;Cell. Signal.,2013

5. Distribution of orexin receptor mRNA in the rat brain;Trivedi;FEBS Lett.,1998

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graph convolutional network with attention mechanism improve major depressive depression diagnosis based on plasma biomarkers and neuroimaging data;Journal of Affective Disorders;2024-09

2. Orexin-A promotes neurite outgrowth and induces activity-regulated cytoskeleton associated protein (Arc) upregulation in SH-SY5Y cells;2024-04-08

3. Contribution of changes in the orexin system and energy sensors in the brain in depressive disorder - a study in an animal model;Pharmacological Reports;2024-01-09

4. Musclin prevents depression-like behavior in male mice by activating urocortin 2 signaling in the hypothalamus;Frontiers in Endocrinology;2023-12-05

5. Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies;Frontiers in Neuroendocrinology;2023-04